Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Carbohydrate doai
Reexamination Certificate
2007-07-03
2007-07-03
Peselev, Elli (Department: 1623)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Carbohydrate doai
Reexamination Certificate
active
10401522
ABSTRACT:
The invention provides hyaluronic acid compounds and derivatives thereof for preventing urogenital infections by a variety of pathogens, as well as compositions, articles and methods for treating and preventing urogenital infections.
REFERENCES:
patent: 4051842 (1977-10-01), Hazel et al.
patent: 4140122 (1979-02-01), Kuhl et al.
patent: 4141973 (1979-02-01), Balazs
patent: 4383529 (1983-05-01), Webster
patent: 4615697 (1986-10-01), Robinson
patent: 4665060 (1987-05-01), Mardh et al.
patent: 4725585 (1988-02-01), Wenge et al.
patent: 4746504 (1988-05-01), Nimrod et al.
patent: 4762824 (1988-08-01), Kallenius et al.
patent: 4784991 (1988-11-01), Nimrod et al.
patent: 4851521 (1989-07-01), Della Valle et al.
patent: 4855128 (1989-08-01), Lynch et al.
patent: 5002759 (1991-03-01), Gaffar et al.
patent: 5401723 (1995-03-01), Gaffar et al.
patent: 5409902 (1995-04-01), Carson et al.
patent: 5514665 (1996-05-01), Speert et al.
patent: 5591724 (1997-01-01), Morales et al.
patent: 5604200 (1997-02-01), Taylor-McCord
patent: 5650432 (1997-07-01), Walker et al.
patent: 5700458 (1997-12-01), Mandeville, III et al.
patent: 5795958 (1998-08-01), Rao et al.
patent: 5840322 (1998-11-01), Weiss et al.
patent: 5883079 (1999-03-01), Zopf et al.
patent: 6051701 (2000-04-01), Cialdi et al.
patent: 6063773 (2000-05-01), Anderson et al.
patent: 6224857 (2001-05-01), Romeo et al.
patent: 6290959 (2001-09-01), Wu et al.
patent: 6375963 (2002-04-01), Repka et al.
patent: 6417173 (2002-07-01), Roufa et al.
patent: 2003/0204180 (2003-10-01), Huang et al.
patent: 2005/0095219 (2005-05-01), Yang et al.
patent: 19813234 (1999-09-01), None
patent: 0656215 (1995-06-01), None
patent: 0769298 (1997-04-01), None
patent: 0962202 (1999-12-01), None
patent: 1275395 (2003-01-01), None
patent: 09-208476 (1997-08-01), None
patent: 2002238995 (2002-08-01), None
patent: WO-9417840 (1994-08-01), None
patent: WO-9603973 (1996-02-01), None
patent: WO-00/45804 (2000-08-01), None
patent: WO-02/24223 (2002-03-01), None
patent: WO-04093887 (2004-11-01), None
An, Yuehuei H., et al., “Concise review of mechanisms of bacterial adhesion to biomaterial surfaces”,Journal of Biomedical Materials Research, 43(3), (Fall 1998),338-348.
Chaffin, W L., et al., “Cell wall and secreted proteins ofCandida albicans: identification, function, and expression”,Microbiology&Molecular Biology Reviews, 62(1), (Mar. 1998), 130-80.
Cho, S Y., et al., “Opportunistic fungal infection among cancer patients”,American Journal of Clinical Pathology, 72(4), (Oct. 1979),617-21.
Connell, H , et al., “Fimbriae-mediated adherence induces mucosal inflammation and bacterial clearance”,In: Toward anti-adhesion therapy for microbial diseases by Itzhak Kahane ; Itzhak Ofek, New York : Plenum Press,(1996),73-80.
Cunningham, M W., “Pathogenesis of group A streptococcal infections”,Clinical Microbiology Reviews, 13(3), (Jul. 2000),470-511.
Goodison, S , et al., “CD44 cell adhesion molecules”,Molecular Pathology, 52(4), (Aug. 1999),189-96.
Hardingham, Timothy E., et al., “Aggrecan, the Chondroitin Sulfate/Keratan Sulfate Proteoglycan from Cartilage”,In: Articular Cartilage and Osteoarthritis, edited by Klaus E. Kuetner et al., New York : Raven Press,(1992),5-20.
Hardingham, Timothy E., et al., “BBA Report. The specific interaction of hyaluronic acid with cartilage proteoglycans”,Biochimica et Biophysica Acta, 279, (1972),401-405.
Hardingham, Timothy E., et al., “Hyaluronic Acid in Cartilage and Proteoglycan Aggregation”,Biochemical Journal, 139(3), (Jun. 1974),565-581.
Hardingham, Timothy E., “The role of link-protein in the structure of cartilage proteoglycan aggregates”,Biochemical Journal, 177(1), (Jan. 1, 1979),237-247.
Heinegard, Dick , et al., “Aggregation of cartilage proteoglycans. 3. Characteristics of the proteins isolated from trypsin digests of aggregates”,Journal of Biological Chemistry, 249(13), (Jul. 10, 1974),4250-4256.
Hornef, M W., et al., “Bacterial strategies for overcoming host innate and adaptive immune responses”,Nature Immunology, 3(11), (Nov. 2002),1033-40.
Hultgren, S J., et al., “Bacterial adhesins and their assembly”,In: Escherichia coli and Salmonella : cellular and molecular biology/Frederick C Neidhardt; Roy Curtiss, Washington, D.C. : ASM Press,(1996),2730-2756.
Kahane, Itzhak , et al., “Toward anti-adhesion therapy for microbial diseases”,New York : Plenum Press, Fimbriae-Mediated Adherence Induces Mucosal Inflammation and Bacterial Clearance: Consequences for Anti-Adhesion Therapy by H. Connell et al,(1996),73-80.
Klotz, S. A., “Adherence of Candida Albicans to Components of the Subendothelial Extracellular Matrix”,FEMS Microbiology Letters, 68 (3), Elsevier Science Publishers, Amsterdam, NL,(Mar. 15, 1990),249-253.
Luo, et al., “Modification of Natural Polymers: Hyaluronic Acid”,In: Methods in Tissue Engineering; Anthony Atala; R P Lanza(eds.), San Diego, CA :; Academic Press,(2001),539-553.
Mobastery, S , et al., “Bacterial antibiotic resistance”,In: Encyclopedia of life sciences/Nature Publishing Company, London ; New York : Nature Pub. Group,(2002).
Muhldorfer, I , et al., “Escherichia coliin urinary tract infections”,In: Molecular medical microbiology / Max Sussman, San Diego : Academic Press,(2002),1515-1540.
Ofek, I , “Adhesins as lectins: specificity and role in infection”,Current Topics in Microbiology&Immunology, 151, (1990),91-113.
Petrin, D , et al., “Clinical and microbiological aspects of Trichomonas vaginalis”,Clinical Microbiology Reviews, 11(2): (Apr. 1998),300-17.
Reid, G , “Probiotics for urogenital health”,Nutrition in Clinical Care, 5(1), (Jan.-Feb. 2002),3-8.
Schoor, Richard A., et al., “Secretory IgA differentially promotes adherence of type 1-piliatedEscherichia colito immortalized vaginal epithelial cell lines”,Urology, 57(3), (Mar. 2001),556-561.
Sharon, N , “Bacterial lectins, cell-cell recognition and infectious disease”,FEBS Letters, 217(2), (Jun. 15, 1987),145-57.
Shnayerson, M , “The killer bug”,Fortune(Industrial Edition), 146(6), (2002),149-156.
Varki, A , “Biological roles of oligosaccharides: all of the theories are correct”,Glycobiology, 3(2), (Apr. 1993),97-130.
Walsh, C , “Molecular mechanisms that confer antibacterial drug resistance”,Nature, 406(6797), (Aug. 17, 2000),775-81.
Zopf, D , et al., “Oligosaccharide anti-infective agents”,Lancet, 347(9007), (Apr. 13, 1996),1017-21.
Alho, Anna M., et al., “The Hyaluronate Receptor Is Preferentially Expressed on Proliferating Epithelial Cells”,The Journal of Cell Biology, 108, (1989), 1557-1565.
Laurent, C., et al., “Localization and quantity of hyaluronan in urogenital organs of male and female rats”,Cell Tissue Research, 279, (1995), 241-248.
Lee, Janet Y., et al., “Hyaluronan: a multifunctional, megaDalton, stealth molecule”,Current Opinion in Cell Biology, 12, (2000), 581-586.
Lesley, Jayne, et al., “Hyaluronan Binding by Cell Surface CD44”,The Journal of Biological Chemistry, 275, (Sep. 2000), 26967-26575.
Mammen, Mathai, et al., “Polyvalent Interactions in Biological Systems: Implications for Design and Use of Multivalent Ligands and Inhibitors”,Angewandte Chemie International Ed., 37 (1998), 2754-2794.
Okada, M., “Molecular design and syntheses of glycopolymers”,Progress in Polymer Science, 26, (2001), 67-104.
Sackmann, Erich, et al., “Cell Adhesion as Wetting Transition?”,Chemphyschem, 3, (2002), 262-269.
Simon, P. M., et al., “Inhibition of Helicobacter pylori Binding to Gastrointestinal Epithelial Cells by Sialic Acid-Containing Oligosaccharides”,Infection and Immunity, 65(2), (Feb. 1997), 750-757.
Yoshizumi, Akira, et al., “Self-Assembled Monolay
Huang Yanbin
Weart Ilona F.
Yang Shu-Ping
Kimberly--Clark Worldwide, Inc.
Peselev Elli
Schwegman Lundberg Woessner & Kluth P.A.
LandOfFree
Prevention of urogenital infections does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Prevention of urogenital infections, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Prevention of urogenital infections will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3784629